Archive - Bio Breakdowns

Biotech Analysis: From 0 to 1

Breaking down my process with a couple examples. End with the future of the blog and Subradata

Mar 18 •

Adu Subramanian

February 2025

January 2025

How Does Roivant Work?

Jan 14 •

Adu Subramanian

December 2024

FDA and regulatory flexibility

An exploration into FDA flexibility for rare diseases, setting the stage for the next 4 years

Dec 20, 2024 •

Adu Subramanian

November 2024

October 2024

FDA flexibility with Capricor

FDA wants your drug to be approved. Let's look at Capricor, Lexeo, and Rocket

Oct 14, 2024 •

Adu Subramanian

September 2024

Spinal Muscular Atrophy and Myostatin

$SRRK, $BHVN, $RHBBY all have upcoming readouts. Let's break it down

Sep 23, 2024 •

Adu Subramanian

August 2024

ATTR-CM and ESC

Does the timing of separation matter?

Aug 15, 2024 •

Adu Subramanian

June 2024

Some data, thoughts, 4 ways to play the space pre AVTE

Jun 14, 2024 •

Adu Subramanian

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts